| Reduction of endoplasmic reticulum stress using chemical chaperones or Grp78 overexpression does not protect muscle cells from palmitate-induced insulin resistance. Rieusset J., Chauvin M.A., Durand A., Bravard A., Laugerette F., Michalski M.C., Vidal H.
Biochem. Biophys. Res. Commun. 417:439-445(2012) · Mapped (10) |
| Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Frojdo S., Durand C., Molin L., Carey A.L., El-Osta A., Kingwell B.A., Febbraio M.A., Solari F., Vidal H., Pirola L.
Mol. Cell. Endocrinol. 335:166-176(2011) · Mapped (14) |
| Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Bravard A., Bonnard C., Durand A., Chauvin M.A., Favier R., Vidal H., Rieusset J.
Am. J. Physiol. Endocrinol. Metab. 300:E581-91(2011) · Mapped (7) |
| FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. Bravard A., Lefai E., Meugnier E., Pesenti S., Disse E., Vouillarmet J., Peretti N., Rabasa-Lhoret R., Laville M., Vidal H. et al.
Diabetes 60:258-268(2011) · Mapped (4) |
| Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Dray C., Debard C., Jager J., Disse E., Daviaud D., Martin P., Attane C., Wanecq E., Guigne C., Bost F. et al.
Am. J. Physiol. Endocrinol. Metab. 298:E1161-9(2010) · Mapped (6) |
| Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis. Jager J., Gremeaux T., Gonzalez T., Bonnafous S., Debard C., Laville M., Vidal H., Tran A., Gual P., Le Marchand-Brustel Y. et al.
Diabetes 59:61-70(2010) · Mapped (10) |
| Claudin 11 deficiency in mice results in loss of the Sertoli cell epithelial phenotype in the testis. Mazaud-Guittot S., Meugnier E., Pesenti S., Wu X., Vidal H., Gow A., Le Magueresse-Battistoni B.
Biol. Reprod. 82:202-213(2010) · Mapped (1) |
| The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway. Granjon A., Gustin M.P., Rieusset J., Lefai E., Meugnier E., Guller I., Cerutti C., Paultre C., Disse E., Rabasa-Lhoret R. et al.
Diabetes 58:2555-2564(2009) · Mapped (13) |
| Microarray analysis of genes with impaired insulin regulation in the skeletal muscle of type 2 diabetic patients indicates the involvement of basic helix-loop-helix domain-containing, class B, 2 protein (BHLHB2). Rome S., Meugnier E., Lecomte V., Berbe V., Besson J., Cerutti C., Pesenti S., Granjon A., Disse E., Clement K. et al.
Diabetologia 52:1899-1912(2009) · Mapped (3) |
| Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men. Faraj M., Beauregard G., Tardif A., Loizon E., Godbout A., Cianflone K., Vidal H., Rabasa-Lhoret R.
Diabetes Metab. 34:334-342(2008) · Mapped (11) |
| Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Rome S., Lecomte V., Meugnier E., Rieusset J., Debard C., Euthine V., Vidal H., Lefai E.
Physiol. Genomics 34:327-337(2008) · Mapped (9) |
| Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice. Bonnard C., Durand A., Vidal H., Rieusset J.
Diabetes Metab. 34:52-61(2008) · Mapped (2) |
| Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients. Cozzone D., Frojdo S., Disse E., Debard C., Laville M., Pirola L., Vidal H.
Diabetologia 51:512-521(2008) · Mapped (7) |
| Molecular mechanisms of diabetes reversibility after bariatric surgery. Rosa G., Mingrone G., Manco M., Euthine V., Gniuli D., Calvani R., Calvani M., Favuzzi A.M., Castagneto M., Vidal H.
Int J Obes (Lond) 31:1429-1436(2007) · Mapped (1) |
| Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Cadoudal T., Blouin J.M., Collinet M., Fouque F., Tan G.D., Loizon E., Beale E.G., Frayn K.N., Karpe F., Vidal H. et al.
Diabetologia 50:666-675(2007) · Mapped (1) |
| Short-term activation of peroxysome proliferator-activated receptor beta/delta increases fatty acid oxidation but does not restore insulin action in muscle cells from type 2 diabetic patients. Debard C., Cozzone D., Ricard N., Vouillarmet J., Disse E., Husson B., Laville M., Vidal H.
J. Mol. Med. 84:747-752(2006) · Mapped (5) |
| Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone. Tan G.D., Olivecrona G., Vidal H., Frayn K.N., Karpe F.
Diabetologia 49:2412-2418(2006) · Mapped (9) |
| Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells. Cozzone D., Debard C., Dif N., Ricard N., Disse E., Vouillarmet J., Rabasa-Lhoret R., Laville M., Pruneau D., Rieusset J. et al.
Diabetologia 49:990-999(2006) · Mapped (14) |
| Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Bach D., Naon D., Pich S., Soriano F.X., Vega N., Rieusset J., Laville M., Guillet C., Boirie Y., Wallberg-Henriksson H. et al.
Diabetes 54:2685-2693(2005) · Mapped (5) |
| Changes in fat mass influence SREBP-1c and UCP-2 gene expression in formerly obese subjects. Gniuli D., Rosa G., Manco M., Scarfone A., Vega N., Greco A.V., Castagneto M., Vidal H., Mingrone G.
Obes. Res. 13:567-573(2005) · Mapped (10) |
| Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues. Gosmain Y., Dif N., Berbe V., Loizon E., Rieusset J., Vidal H., Lefai E.
J. Lipid Res. 46:697-705(2005) · Mapped (4) |
| Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Rieusset J., Bouzakri K., Chevillotte E., Ricard N., Jacquet D., Bastard J.P., Laville M., Vidal H.
Diabetes 53:2232-2241(2004) · Mapped (5) |
| Increased adipose tissue expression of Grb14 in several models of insulin resistance. Cariou B., Capitaine N., Le Marcis V., Vega N., Bereziat V., Kergoat M., Laville M., Girard J., Vidal H., Burnol A.F.
FASEB J. 18:965-967(2004) · Mapped (9) |
| Sterol regulatory element-binding protein-1 mediates the effect of insulin on hexokinase II gene expression in human muscle cells. Gosmain Y., Lefai E., Ryser S., Roques M., Vidal H.
Diabetes 53:321-329(2004) · Mapped (15) |
| Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects. Rosa G., Manco M., Vega N., Greco A.V., Castagneto M., Vidal H., Mingrone G.
Obes. Res. 11:1306-1312(2003) · Mapped (5) |
